BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:166-76. [PMID: 26566463 DOI: 10.1007/s40142-015-0075-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 van der Schoot V, Haer-Wigman L, Feenstra I, Tammer F, Oerlemans AJM, van Koolwijk MPA, van Agt F, Arens YHJM, Brunner HG, Vissers LELM, Yntema HG. Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals. Eur J Hum Genet 2021. [PMID: 34697415 DOI: 10.1038/s41431-021-00964-0] [Reference Citation Analysis]
2 Langer MM, Roche MI, Brewer NT, Berg JS, Khan CM, Leos C, Moore E, Brown M, Rini C. Development and Validation of a Genomic Knowledge Scale to Advance Informed Decision Making Research in Genomic Sequencing. MDM Policy Pract 2017;2. [PMID: 29928697 DOI: 10.1177/2381468317692582] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
3 Anderson JL, Pilarski R, Kirschner L, Brock P. Genetic evaluation of patients and families with concern for hereditary endocrine tumor syndromes. Fam Cancer 2021. [PMID: 33409929 DOI: 10.1007/s10689-020-00222-0] [Reference Citation Analysis]
4 Rost C, Dent KM, Botkin J, Rothwell E. Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients. J Genet Couns 2020;29:1234-44. [PMID: 32453499 DOI: 10.1002/jgc4.1292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Tucker EJ, Grover SR, Bachelot A, Touraine P, Sinclair AH. Premature Ovarian Insufficiency: New Perspectives on Genetic Cause and Phenotypic Spectrum. Endocr Rev 2016;37:609-35. [PMID: 27690531 DOI: 10.1210/er.2016-1047] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 16.0] [Reference Citation Analysis]
6 Patrinos G, Danielson P, Ansorge W. Molecular Diagnostics. Molecular Diagnostics. Elsevier; 2017. pp. 1-11. [DOI: 10.1016/b978-0-12-802971-8.00001-8] [Cited by in Crossref: 8] [Article Influence: 1.6] [Reference Citation Analysis]
7 Liu H, Gao M, Gu J, Wan X, Wang H, Gu Q, Zhou Y, Sun X. VEGFR1-Targeted Contrast-Enhanced Ultrasound Imaging Quantification of Vasculogenic Mimicry Microcirculation in a Mouse Model of Choroidal Melanoma. Transl Vis Sci Technol 2020;9:4. [PMID: 32704424 DOI: 10.1167/tvst.9.3.4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Roche MI, Griesemer I, Khan CM, Moore E, Lin FC, O'Daniel JM, Foreman AKM, Lee K, Powell BC, Berg JS, Evans JP, Henderson GE, Rini C. Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings. Genet Med 2019;21:1092-9. [PMID: 30237575 DOI: 10.1038/s41436-018-0294-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Tan N, Amendola LM, O'Daniel JM, Burt A, Horike-Pyne MJ, Boshe L, Henderson GE, Rini C, Roche MI, Hisama FM, Burke W, Wilfond B, Jarvik GP. Is "incidental finding" the best term?: a study of patients' preferences. Genet Med 2017;19:176-81. [PMID: 27490114 DOI: 10.1038/gim.2016.96] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
10 Rossing M, Sørensen CS, Ejlertsen B, Nielsen FC. Whole genome sequencing of breast cancer. APMIS 2019;127:303-15. [PMID: 30689231 DOI: 10.1111/apm.12920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Rini C, Roche MI, Lin FC, Foreman AKM, Khan CM, Griesemer I, Waltz M, Lee K, O'Daniel JM, Evans JP, Berg JS, Henderson GE. Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial. Patient Educ Couns 2021:S0738-3991(21)00291-3. [PMID: 33966955 DOI: 10.1016/j.pec.2021.04.026] [Reference Citation Analysis]
12 Winkler EC, Wiemann S. Findings made in gene panel to whole genome sequencing: data, knowledge, ethics – and consequences? Expert Review of Molecular Diagnostics 2016;16:1259-70. [DOI: 10.1080/14737159.2016.1212662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
13 Matsui K, Yamamoto K, Tashiro S, Ibuki T. A systematic approach to the disclosure of genomic findings in clinical practice and research: a proposed framework with colored matrix and decision-making pathways. BMC Med Ethics 2021;22:168. [PMID: 34953504 DOI: 10.1186/s12910-021-00738-9] [Reference Citation Analysis]
14 Sommen M, Wuyts W, Van Camp G. Molecular diagnostics for hereditary hearing loss in children. Expert Rev Mol Diagn 2017;17:751-60. [PMID: 28593790 DOI: 10.1080/14737159.2017.1340834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fischer J, Rohena L, Mittal B. Novel Phenotype in Unbalanced 7;9 Translocation with Critical Incidental Finding. Case Reports in Genetics 2022;2022:1-5. [DOI: 10.1155/2022/7510079] [Reference Citation Analysis]
16 Barwell J, Snape K, Wedderburn S. The new genomic medicine service and implications for patients . Clin Med (Lond) 2019;19:273-7. [PMID: 31308102 DOI: 10.7861/clinmedicine.19-4-273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Schilit SL, Schilit Nitenson A. My Identical Twin Sequenced our Genome. J Genet Couns 2017;26:276-8. [PMID: 27853911 DOI: 10.1007/s10897-016-0046-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Newey PJ. Clinical genetic testing in endocrinology: Current concepts and contemporary challenges. Clin Endocrinol 2019;91:587-607. [DOI: 10.1111/cen.14053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Murrell JR, Nesbitt AMI, Baker SW, Pechter KB, Balciuniene J, Zhao X, Denenberg EH, DeChene ET, Wu C, Jayaraman P, Cao K, Gonzalez M, Devoto M, Testori A, Monos JD, Dulik MC, Conlin LK, Luo M, McDonald Gibson K, Guan Q, Sarmady M, Bhoj E, Helbig I, Zackai EH, Bedoukian EC, Wilkens A, Tarpinian J, Izumi K, Skraban CM, Deardorff MA, Medne L, Krantz ID, Krock BL, Santani AB. Molecular Diagnostic Outcomes from 700 Cases: What Can We Learn from a Retrospective Analysis of Clinical Exome Sequencing? J Mol Diagn 2022;24:274-86. [PMID: 35065284 DOI: 10.1016/j.jmoldx.2021.12.002] [Reference Citation Analysis]
20 Mandelker D, Donoghue M, Talukdar S, Bandlamudi C, Srinivasan P, Vivek M, Jezdic S, Hanson H, Snape K, Kulkarni A, Hawkes L, Douillard JY, Wallace SE, Rial-Sebbag E, Meric-Bersntam F, George A, Chubb D, Loveday C, Ladanyi M, Berger MF, Taylor BS, Turnbull C. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Ann Oncol 2019;30:1221-31. [PMID: 31050713 DOI: 10.1093/annonc/mdz136] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 21.5] [Reference Citation Analysis]
21 Balicza P, Terebessy A, Grosz Z, Varga NA, Gal A, Fekete BA, Molnar MJ. Implementation of personalized medicine in Central-Eastern Europe: pitfalls and potentials based on citizen's attitude. EPMA J 2018;9:103-12. [PMID: 29515690 DOI: 10.1007/s13167-017-0125-3] [Reference Citation Analysis]
22 Bunnik EM, Dondorp WJ, Bredenoord AL, de Wert GMWR, Cornel MC. Response to letter entitled: Re: Mainstreaming informed consent for genomic sequencing: A call for action: Discussing opt-out options during informed consent discussions in mainstream settings. Eur J Cancer 2021;155:310-2. [PMID: 34391611 DOI: 10.1016/j.ejca.2021.06.041] [Reference Citation Analysis]
23 Gladbach YS, Wiegele L, Hamed M, Merkenschläger AM, Fuellen G, Junghanss C, Maletzki C. Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1-/- Mice. Cancers (Basel) 2019;11:E1485. [PMID: 31581674 DOI: 10.3390/cancers11101485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Eggert J. Genetics and Genomics in Oncology Nursing: What Does Every Nurse Need to Know? Nurs Clin North Am 2017;52:1-25. [PMID: 28189157 DOI: 10.1016/j.cnur.2016.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Cheung F, Birch P, Friedman JM, Elliott AM, Adam S; CAUSES Study, GenCOUNSEL Study. The long‐term impact of receiving incidental findings on parents undergoing genome‐wide sequencing. Journal of Genetic Counseling. [DOI: 10.1002/jgc4.1558] [Reference Citation Analysis]
26 Fenwick A, Plantinga M, Dheensa S, Lucassen A. Predictive Genetic Testing of Children for Adult-Onset Conditions: Negotiating Requests with Parents. J Genet Couns 2017;26:244-50. [PMID: 27680566 DOI: 10.1007/s10897-016-0018-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
27 Mackley MP, Capps B. Expect the unexpected: screening for secondary findings in clinical genomics research. Br Med Bull 2017;122:109-22. [PMID: 28398474 DOI: 10.1093/bmb/ldx009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
28 Bombard Y, Clausen M, Mighton C, Carlsson L, Casalino S, Glogowski E, Schrader K, Evans M, Scheer A, Baxter N, Hamilton JG, Lerner-Ellis J, Offit K, Robson M, Laupacis A. The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results. Eur J Hum Genet 2018;26:984-95. [PMID: 29703952 DOI: 10.1038/s41431-018-0144-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
29 Lewis MA, Paquin RS, Roche MI, Furberg RD, Rini C, Berg JS, Powell CM, Bailey DB Jr. Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid. Pediatrics 2016;137 Suppl 1:S16-23. [PMID: 26729698 DOI: 10.1542/peds.2015-3731E] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
30 Hoang N, Cytrynbaum C, Scherer SW. Communicating complex genomic information: A counselling approach derived from research experience with Autism Spectrum Disorder. Patient Educ Couns 2018;101:352-61. [PMID: 28803755 DOI: 10.1016/j.pec.2017.07.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
31 Ballinger ML, Pinese M, Thomas DM. Translating genomic risk into an early detection strategy for sarcoma. Genes Chromosomes Cancer 2019;58:130-6. [PMID: 30382615 DOI: 10.1002/gcc.22697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Staley BS, Milko LV, Waltz M, Griesemer I, Mollison L, Grant TL, Farnan L, Roche M, Navas A, Lightfoot A, Foreman AKM, O'Daniel JM, O'Neill SC, Lin FC, Roman TS, Brandt A, Powell BC, Rini C, Berg JS, Bensen JT. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial. Trials 2021;22:395. [PMID: 34127041 DOI: 10.1186/s13063-021-05341-2] [Reference Citation Analysis]
33 Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres. BMC Med Genomics 2019;12:123. [PMID: 31429751 DOI: 10.1186/s12920-019-0561-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Quinn P, Quinn L. Big genetic data and its big data protection challenges. Computer Law & Security Review 2018;34:1000-18. [DOI: 10.1016/j.clsr.2018.05.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.8] [Reference Citation Analysis]
35 Mollison L, O'Daniel JM, Henderson GE, Berg JS, Skinner D. Parents' perceptions of personal utility of exome sequencing results. Genet Med 2020;22:752-7. [PMID: 31857707 DOI: 10.1038/s41436-019-0730-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
36 Jamuar SS, Kuan JL, Brett M, Tiang Z, Tan WL, Lim JY, Liew WK, Javed A, Liew WK, Law HY, Tan ES, Lai A, Ng I, Teo YY, Venkatesh B, Reversade B, Tan EC, Foo R. Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine? EBioMedicine 2016;5:211-6. [PMID: 27077130 DOI: 10.1016/j.ebiom.2016.01.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
37 Antoniou M, Kolamunnage-Dona R, Wason J, Bathia R, Billingham C, Bliss JM, Brown LC, Gillman A, Paul J, Jorgensen AL. Biomarker-guided trials: Challenges in practice. Contemp Clin Trials Commun 2019;16:100493. [PMID: 31788574 DOI: 10.1016/j.conctc.2019.100493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
38 Griesemer I, Moore E, Khan C, Roche M, Henderson G, Rini C. Psychological adaptation to diagnostic genomic sequencing results: The role of hope fulfillment. Health Psychol 2019;38:527-35. [PMID: 30958015 DOI: 10.1037/hea0000733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Berg JS, Agrawal PB, Bailey DB Jr, Beggs AH, Brenner SE, Brower AM, Cakici JA, Ceyhan-Birsoy O, Chan K, Chen F, Currier RJ, Dukhovny D, Green RC, Harris-Wai J, Holm IA, Iglesias B, Joseph G, Kingsmore SF, Koenig BA, Kwok PY, Lantos J, Leeder SJ, Lewis MA, McGuire AL, Milko LV, Mooney SD, Parad RB, Pereira S, Petrikin J, Powell BC, Powell CM, Puck JM, Rehm HL, Risch N, Roche M, Shieh JT, Veeraraghavan N, Watson MS, Willig L, Yu TW, Urv T, Wise AL. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics 2017;139:e20162252. [PMID: 28096516 DOI: 10.1542/peds.2016-2252] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 18.6] [Reference Citation Analysis]
40 Ryan KA, De Vries RG, Uhlmann WR, Roberts JS, Gornick MC. Public's Views toward Return of Secondary Results in Genomic Sequencing: It's (Almost) All about the Choice. J Genet Couns 2017;26:1197-212. [PMID: 28357777 DOI: 10.1007/s10897-017-0095-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
41 Manrique de Lara A, Soto-Gómez L, Núñez-Acosta E, Saruwatari-Zavala G, Rentería ME. Ethical issues in susceptibility genetic testing for late-onset neurodegenerative diseases. Am J Med Genet B Neuropsychiatr Genet 2019;180:609-21. [PMID: 30525300 DOI: 10.1002/ajmg.b.32699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Fawcett GL, Karina Eterovic A. Identification of Genomic Somatic Variants in Cancer: From Discovery to Actionability. Adv Clin Chem 2017;78:123-62. [PMID: 28057186 DOI: 10.1016/bs.acc.2016.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Appelbaum PS, Benston S. Anticipating the Ethical Challenges of Psychiatric Genetic Testing. Curr Psychiatry Rep 2017;19:39. [PMID: 28534296 DOI: 10.1007/s11920-017-0790-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
44 Vu M, Degeling K, Martyn M, Lynch E, Chong B, Gaff C, IJzerman MJ. Evaluating the resource implications of different service delivery models for offering additional genomic findings. Genet Med 2021;23:606-13. [PMID: 33214711 DOI: 10.1038/s41436-020-01030-8] [Reference Citation Analysis]
45 Milko LV, O'Daniel JM, DeCristo DM, Crowley SB, Foreman AKM, Wallace KE, Mollison LF, Strande NT, Girnary ZS, Boshe LJ, Aylsworth AS, Gucsavas-Calikoglu M, Frazier DM, Vora NL, Roche MI, Powell BC, Powell CM, Berg JS. An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening. J Pediatr 2019;209:68-76. [PMID: 30851990 DOI: 10.1016/j.jpeds.2018.12.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
46 Stoll K, Kubendran S, Cohen SA. The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine. Am J Med Genet 2018;178:24-37. [DOI: 10.1002/ajmg.c.31602] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 16.5] [Reference Citation Analysis]
47 Gupta S, Smith TR, Broekman ML. Ethical considerations of neuro-oncology trial design in the era of precision medicine. J Neurooncol 2017;134:1-7. [PMID: 28555425 DOI: 10.1007/s11060-017-2502-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Saelaert M, Mertes H, De Baere E, Devisch I. Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 2018;26:1424-31. [PMID: 29970927 DOI: 10.1038/s41431-018-0200-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
49 Aradhya S, Nussbaum RL. Genetics in mainstream medicine: Finally within grasp to influence healthcare globally. Mol Genet Genomic Med 2018. [PMID: 29807392 DOI: 10.1002/mgg3.415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Saelaert M, Mertes H, Moerenhout T, Van Cauwenbergh C, Leroy BP, Devisch I, De Baere E. A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings. Sci Rep 2021;11:15834. [PMID: 34349199 DOI: 10.1038/s41598-021-95258-2] [Reference Citation Analysis]
51 Ghouse J, Skov MW, Bigseth RS, Ahlberg G, Kanters JK, Olesen MS. Distinguishing pathogenic mutations from background genetic noise in cardiology: The use of large genome databases for genetic interpretation. Clin Genet 2018;93:459-66. [PMID: 28589536 DOI: 10.1111/cge.13066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
52 Fowler SA, Saunders CJ, Hoffman MA. Variation among Consent Forms for Clinical Whole Exome Sequencing. J Genet Couns 2018;27:104-14. [PMID: 28689263 DOI: 10.1007/s10897-017-0127-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
53 He KY, Zhao Y, McPherson EW, Li Q, Xia F, Weng C, Wang K, He MM. Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records. PLoS One 2016;11:e0167847. [PMID: 27930734 DOI: 10.1371/journal.pone.0167847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Rini C, Khan CM, Moore E, Roche MI, Evans JP, Berg JS, Powell BC, Corbie-Smith G, Foreman AKM, Griesemer I, Lee K, O'Daniel JM, Henderson GE. The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study. Genet Med 2018;20:760-9. [PMID: 29261173 DOI: 10.1038/gim.2017.176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
55 Clowes Candadai SV, Sikes MC, Thies JM, Freed AS, Bennett JT. Rapid clinical exome sequencing in a pediatric ICU: Genetic counselor impacts and challenges. J Genet Couns 2019;28:283-91. [PMID: 30964580 DOI: 10.1002/jgc4.1116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
56 Bianchi L, Liò P. Opportunities for community awareness platforms in personal genomics and bioinformatics education. Brief Bioinform 2017;18:1082-90. [PMID: 27580620 DOI: 10.1093/bib/bbw078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]